Bristol Myers Squibb, US1101221083

Bristol Myers Squibb stock stands at EUR 53.24, USD 121.8 billion market capatization

Published on 10/09/2026 at 20:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

On October 9, 2026, Bristol Myers Squibb stock costs EUR 53.24 after EUR 53.52. Market value is USD 121.8 billion, P/E is 13.1, and results are due October 29, 2026.

Key points in brief

  • Bristol Myers Squibb stock was EUR 53.24 after-hours on October 9, 2026, down 0.52 percent versus EUR 53.52.
  • The company had a USD 121.8 billion market capitalization and a 13.1 P/E ratio.
  • Third-quarter results are scheduled for October 29, 2026, while AbbVie and Johnson & Johnson posted larger same-day gains.
Bristol Myers Squibb, US1101221083, Illustration mit AI erstellt.
Bristol Myers Squibb, US1101221083, Illustration mit AI erstellt.

Bristol Myers Squibb (ISIN US1101221083) was trading at EUR 53.24 at Lang & Schwarz on October 9, 2026 at 7:56 p.m. CEST, minus 0.52 percent versus the prior close of EUR 53.52. The after-hours quote gives German investors a separate euro view of a stock whose primary listing is on the NYSE.

Intraday quote and range

The Lang & Schwarz bid was EUR 53.14 and the ask was EUR 53.34 at the same timestamp. On the NYSE, the stock was last at USD 59.60 at 2:00 p.m. ET on October 9, 2026.

The USD 42.52 to USD 68.64 52-week range places the primary-exchange quote 13.17 percent below its yearly high. The calculation uses the USD 59.60 quote and the USD 68.64 high, keeping the two values in the same currency.

Market value and valuation

Bristol Myers Squibb had a market capitalization of USD 121.8 billion and a P/E ratio of 13.1 as of October 9, 2026. The valuation figure is the headline context for the EUR 53.24 Lang & Schwarz price, but the currencies are not combined.

The company's next scheduled reporting date is October 29, 2026, when it will report third-quarter 2026 results, according to Bristol Myers Squibb in its September 18, 2026 release.

Comparison with peers

Bristol Myers Squibb: minus 0.52 percent, P/E 13.1, market capitalization USD 121.8 billion

AbbVie (NYSE, USD): plus 1.70 percent, P/E 78.1, market capitalization USD 489.5 billion

Johnson & Johnson (NYSE, USD): plus 1.77 percent, P/E 30.3, market capitalization USD 629.0 billion

Euro quote after the Xetra close

The Lang & Schwarz price stood at EUR 53.24 after-hours on October 9, 2026 at 7:56 p.m. CEST, minus 0.52 percent versus the Lang & Schwarz prior close of EUR 53.52. The separate NYSE quote of USD 59.60 was dated October 9, 2026 at 2:00 p.m. ET.

The further course of trading is shown by the continuously updated real-time quote of Bristol Myers Squibb stock.

Bristol Myers Squibb stock facts

  • Company: Bristol-Myers Squibb Company
  • ISIN: US1101221083
  • Ticker: BMY
  • Primary exchange: NYSE
  • Price Lang & Schwarz as of October 9, 2026, 7:56 p.m. CEST: EUR 53.24
  • Change versus prior close: minus 0.52 percent
  • Prior close Lang & Schwarz October 8, 2026: EUR 53.52
  • Market capitalization: USD 121.8 billion as of October 9, 2026
  • 52-week range: USD 42.52-USD 68.64 as of October 9, 2026
  • Sector / Industry: Health Care / Pharmaceuticals
  • Index membership: S&P 500
  • Next earnings date: October 29, 2026

Market context: Market report S&P 500.

More news and analyses on Bristol Myers Squibb stock

Disclaimer...

en | US1101221083 | BRISTOL MYERS SQUIBB | boerse | 70282714 | bgmi